Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Dingdang Kuaiyao

Request full access

Dingdang Kuaiyao is an online-to-offline drug purchasing and delivery platform

Dongcheng District, ChinaFounded 2014Health Tech & Medtech

About Dingdang Kuaiyao

Dingdang Kuaiyao, which also operates under the name Dingdang Health, is a Chinese online-to-offline (O2O) platform for healthcare services, established in 2014 by founder and Chairman Yang Wenlong. Yang also serves as the CEO of Renhe Yaoye, a pharmaceutical developer, manufacturer, and retailer, a background that informed the creation of Dingdang Kuaiyao to address the unmet need for rapid medicine delivery.

The company's core business revolves around its mobile app and network of self-operated smart pharmacies, which provide 24/7 on-demand delivery of over-the-counter medicines and other healthcare products. A key feature of its service is the promise of delivery within 28 minutes in the cities it serves, a proposition that attracted early users, especially those needing medicine at night. The business operates on an asset-heavy model, directly managing its own pharmacies and logistics to ensure service speed and reliability. This self-supporting structure differentiates it from competitors that rely on third-party delivery platforms. Revenue is generated from the sale of pharmaceutical and healthcare products through its online platform and offline stores.

Beyond rapid delivery, Dingdang Kuaiyao has expanded its services to include online medical consultations, chronic disease management, and psychological counseling, leveraging AI and big data to enhance its offerings. The platform has experienced significant growth, fueled by substantial venture capital funding from investors such as SoftBank China, CMB International, TPG Capital Asia, and OrbiMed. This capital has supported its aggressive expansion plan across major Chinese cities. The company successfully listed on the Hong Kong Stock Exchange in September 2022.

Source: Dealroom company data

At a glance

Status
Closed
Employees
147
Open positions
1
Industry
Health
Sub-industry
Health Platform
Sector
Pharmacy, Tech for Patients, Rumoured $1B
Client focus
B2C

Funding history

5 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
LATE VCOther financing Jun 2021 $220M $880M OrbiMed · Summer Capital · Valliance Capital · TPG —
SERIES COther financing Oct 2020 $138M $550M Haier Biomedical · CICC · SB China Capital · Taikang Life Insurance —
Showing the latest 2 of 5 recorded eventsBook a demo for the full funding history →

Growth signals

Dingdang Kuaiyao website traffic

Latest recorded traffic for Dingdang Kuaiyao is 0 monthly website visits, down 100% over the last three months. Dingdang Kuaiyao's team grew 0% over the past year.

Latest monthly visits0 3-month web change-100% 1-year team growth0%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Open positions

Openings linked to this company in Dealroom
1 distinct opening shownExplore hiring signals →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Dingdang Kuaiyao in the Dongcheng District ecosystem

Live from Dealroom

The Dingdang Kuaiyao office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

16 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A2 investors entered at this stage

  • Tongdaoo Capital
  • SB China Capital

Series B and later14 investors entered at this stage

  • Haier Biomedical
  • CICC
  • Taikang Life Insurance
  • Sinopharm Healthcare Fund
  • CMB International
  • Longmen Capital
  • OrbiMed
  • Summer Capital
  • Valliance Capital
  • TPG
  • Orchid Asia Group Management
  • Redview Capital
  • Yingke Capital
  • Valliance
Team profiled 2 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇨🇳 China100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Dingdang Kuaiyao on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Dingdang Kuaiyao’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.